AnxA2-deficient mice [122] (Table 2a) provided the first in vivo evidence that AnxA2 mediates fibrin clearance, as the AnxA2−/− mice showed substantial deposition of fibrin and after induction of acute carotic artery thrombosis, displayed increased thrombosis. This evidence concerns the gene ANXA2 and Arterial thrombosis.